Daniel C. Lee is a postdoctoral scholar at University of South Florida Byrd Alzheimer’s Institute in the Department of Molecular Pharmacology and Physiology. A native of Pennsylvania, Daniel received his B.S. degree in chemistry in 1999 at Lincoln University , Pennsylvania and his Ph.D. in pharmacology/ toxicology at Florida A&M University College of Pharmacy and Pharmaceutical Sciences in 2005. His dissertation work involved the role of cystatin C and lysosomal protease alterations following 6-hydroxydopamine induced oxidative stress: Implications in the pathogenesis of Parkinson’s disease. His current research interest focuses on novel therapies for Alzheimer’s disease models and the role of neuroinflammation on tau and amyloid beta pathology. Daniel has received numerous accolades during his tenure at USF including the USF Research Interdisciplinary Postdoctoral Scholar Outstanding Presentation Award, Symposium Winner three times (2007, 2008, and 2009) and seven travel awards to international conferences. He has published in nine peer reviewed journals and has presented his research at 14 international conferences. Daniel is a member of the Society for Neuroscience and The American Society for Neural Therapy and Repair, and has served as a FASEB MARC peer mentor since 2006.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…